Mike Kocsis’ Post

What Effects Did Stress Have on Your Body? #semaglutide #weightloss #ozempic Introduction to semaglutide: Semaglutide is introduced as a once-a-week injection that helps with weight loss. It is considered a promising medication for addressing obesity and associated health concerns. semaglutide journey: Semaglutide is classified as a GLP-1 receptor agonist, originally approved for the treatment of diabetes in 2005. What is the dark side of semaglutide?

GLP-1 receptor agonists, once used exclusively for diabetes treatment, are emerging as a new category of #weightlossmedications with big potential in #obesitymanagement. Their popularity has significantly risen since 2021 when they were first approved for extended weight management. Raul J. Rosenthal, MD, FASMBS, explains how these latest advancements are transforming obesity care: https://cle.clinic/4exgeuW

Resistant hypertension is defined by high #bloodpressure that persists despite taking ≥3 medications, and among the possible causes is dysregulated aldosterone. Read about this hormone's role, and how we're working to address it. #HighBloodPressureMonth

Dysregulated aldosterone production is an under-recognized cause of #hypertension, and mounting evidence points towards obesity as a leading culprit. Learn more about how directly reducing aldosterone synthesis may help in treating uncontrolled hypertension in Healio. #BloodPressureControl #HealthcareInnovation

Curious about semaglutide and insulin? Let's clarify this important distinction. Semaglutide is not insulin; it is a GLP-1 receptor agonist that assists in managing blood sugar levels and promoting weight loss. Unlike insulin, semaglutide offers dual benefits for diabetes and obesity control. If you're considering semaglutide as a treatment, consult the team at Lewiston Weight Loss to learn more. Knowing the unique roles of semaglutide and insulin is key to effective diabetes management. Stay informed and proactive in your health journey.

https://lnkd.in/e-Xyeimx   This article perfectly summarizes the scientific importance of the work we’re doing at Mineralys. Along with #hypertension, the #obesity epidemic is driving dysregulated aldosterone production that contributes to #CKD, heart failure and multiple other cardiorenal diseases.   Lorundrostat is our highly selective aldosterone synthase inhibitor, which demonstrated enhanced efficacy in the patients with an elevated BMI. While currently in pivotal trials for uncontrolled and resistant hypertension, it represents a pipeline of broad #cardiorenal disease opportunities in the future.  #businessdevelopment #lifesciencesindustry

GLP-1 receptor agonists, such as semaglutide and tirzepatide, are effective in treating obesity by mimicking the GLP-1 hormone, which helps regulate appetite and insulin levels. Clinical studies demonstrate that these medications facilitate weight loss by reducing appetite and enhancing glycemic control. However, they may also lead to a decrease in lean muscle mass, which is vital for maintaining metabolic health and overall physical function. To achieve a balanced approach to weight loss, it is essential to focus on preserving lean muscle while losing fat. This balance supports better metabolic outcomes and overall health. At Healthon, we provide personalized support to help you achieve your weight loss goals while preserving muscle mass. Our team is dedicated to offering tailored advice and resources to optimize your health outcomes. Discover more about balancing weight loss and muscle preservation with GLP-1 therapy at Healthon. Learn more ➡️ https://healthon.com/ #HealthGoals #GLP1 #WeightControl #HealthyWeight #DietAndExercise #MedicalTherapy #WeightLossJourney #WeightLossMotivation #GLP1WeightLoss #TelehealthWeightLoss #SustainableWeightLoss #WeightLossTransformation #WeightLossSupport #WeightLossTips #MedicalWeightLoss #FatLoss #ObesityManagement #WeightWatchers #FitnessJourney #HealthyLiving #GetFit #HealthyChoices #BodyTransformation #SlimDown #Ozempic #Semaglutide #Saxenda #Wegovy #Tirzepatide

Diabetes research.. a major step forward in D1 cure. Two drugs that can regenerate insulin production in pancreatic cells damaged by the condition. #diabetes #medicalresearch https://lnkd.in/gVJuSyyb

Are you uncertain about semaglutide's relation to insulin? Let's address this common question. Semaglutide is not insulin; it functions as a GLP-1 receptor agonist, aiding in blood sugar regulation and weight loss. Unlike insulin, semaglutide targets appetite control and digestion to improve diabetes and obesity management. If you're exploring semaglutide as a treatment option, consult the team at Lewiston Weight Loss to learn more. Understanding the differences between semaglutide and insulin is essential for effective treatment strategies. Stay informed and empowered in your healthcare decisions.